Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Jun;29(1):125-132.
doi: 10.1007/s40199-021-00389-6. Epub 2021 Feb 4.

Comparing the cost, glycaemic control and medication adherence of utilizing patients' own medicines (POMs) versus usual dispensing among diabetic patients in an outpatient setting

Affiliations
Randomized Controlled Trial

Comparing the cost, glycaemic control and medication adherence of utilizing patients' own medicines (POMs) versus usual dispensing among diabetic patients in an outpatient setting

Phei Ching Lim et al. Daru. 2021 Jun.

Abstract

Background: Millions worth of unused drugs particularly those indicated for chronic diseases such as diabetes were returned and disposed leading to substantial wastage. Use of patients' own medications (POMs) in the inpatient setting has reduced wastage and saved cost. The impact of utilizing POMs in the outpatient setting has hitherto not been determined.

Purpose: This study aims to compare the cost, medication adherence and glycaemic control of utilizing POMs versus usual dispensing.

Methods: Prospective randomized controlled study was conducted among diabetic patients that required monthly medication refill in the Outpatient Pharmacy in 2017. Patients who consented were equally divided into POMs and control groups. Both groups brought excess medications from home at week-0 and week-12. Patients in the POMs group brought excess medications monthly and sufficient amount of drugs were added until the next refill date. Drugs were dispensed as usual in the control group. Total cost consisting of the cost of drugs, staff and building was calculated. Glycosylated haemoglobin (HbA1c) was measured at baseline and week-12. Adherence was measured based on pill counting.

Results: Thirty patients aged 56.77 ± 14.67 years with 13.37 ± 7.36 years of diabetes participated. Baseline characteristics were similar between the groups. POMs minimized the total cost by 38.96% which translated to a cost saving of USD 42.76 ± 6.98, significantly different versus USD 0.02 ± 0.52 in the control group, p = 0.025. Mean HbA1c reduced significantly (-0.79%, p = 0.016) in the POMs group but not significant in the control group (-0.11%, p = 0.740). Medication adherence improved significantly in both groups at week-12 (p < 0.010). Nevertheless, patients in the POMs group were more adherent, 87.20% vs. 66.32%, p = 0.034.

Conclusion: Utilizing POMs resulted in cost saving, improved adherence and better glycaemic control. Use of POMs should be practiced in the outpatient pharmacy to reduce wastage and cost.

Keywords: Cost; Glycaemic control; Medication adherence; Outpatient; Patients’ own medicines.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Fig. 1
Fig. 1
Study design

References

    1. Trueman P, Lowson K, Blighe A. Evaluation of the scale, causes and costs of waste medicine. Final Report. York Health Economics and University of London. 2010. https://discovery.ucl.ac.uk/id/eprint/1350234. Accessed 20 July 2020.
    1. Law AV, Skahrakar P, Zargarzadeh A, Tai BW, Hess K, Hata M, et al. Taking stock of medication wastage: unused medicines in US household. Res Soc Adm Pharm. 2015;11:571–578. doi: 10.1016/j.sapharm.2014.10.003. - DOI - PubMed
    1. Organisation for Economic Co-operation and Development. OECD Health Data: Social protection. 2014. 10.1787/data-00544-en. Accessed on 20 July 2020.
    1. Reinhardt UE, Cheng T-M. The world health report 2000 - health systems: improving performance. Bull World Health Organ. 2000;78(8):1064.
    1. Feisul IM, Azmi S, Mohd Rizal AM, Zanariah H, Nik Mahir NJ, Fatanah I, et al. What are the direct medical costs of managing Type 2 Diabetes Mellitus in Malaysia? Med J Malaysia. 2017;72:271–277. - PubMed

Publication types

Substances

LinkOut - more resources